Cost-effectiveness analysis of Zostavax in the prevention of Herpes Zoster in Korea

被引：0
|
作者：
Kim, J. [1 ]
Cheong, H. [2 ]
Choi, W. [2 ]
Kang, S. [3 ]
Han, M. [1 ]
Ihm, S. [1 ]
Kim, J. [1 ]
Graham, J. [4 ]
Yi, Z. [4 ]
Johnson, K. [5 ]
机构：
[1] Merck Sharp & Dohme Corp, Seoul, South Korea
[2] Korea Univ, Coll Med, Seoul, South Korea
[3] Konyang Univ, Nonsan, Chungcheongnam, South Korea
[4] RTI Hlth Solut, Res Triangle Pk, NC 27709 USA
[5] Merck & Co Inc, Kenilworth, NJ USA
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2017年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P1-VA07
引用
收藏
页码：S120 / S121
页数：2
相关论文
共 50 条
  • [1] Effectiveness of the herpes zoster vaccine Zostavax
    Lai, Shih-Wei
    [J]. VACCINE, 2020, 38 (52) : 8258 - 8258
  • [2] Cost-Effectiveness of Herpes Zoster Vaccination
    Sriwijitalai, Won
    Wiwanitkit, Viroj
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2019, 10
  • [3] Zostavax: a subcutaneous vaccine for the prevention of herpes zoster
    Doan, Hung Q.
    Ung, Bothland
    Ramirez-Fort, Marigdalia K.
    Khan, Farhan
    Tyring, Stephen K.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (10) : 1467 - 1477
  • [4] COST-EFFECTIVENESS ANALYSIS OF HERPES ZOSTER VACCINATION IN HONG KONG
    Lee, C.
    You, J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A583 - A584
  • [5] A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations
    Prosser, Lisa A.
    Harpaz, Rafael
    Rose, Angela M.
    Gebremariam, Acham
    Guo, Angela
    Ortega-Sanchez, Ismael R.
    Zhou, Fangjun
    Dooling, Kathleen
    [J]. ANNALS OF INTERNAL MEDICINE, 2019, 170 (06) : 380 - +
  • [6] Cost-effectiveness of vaccination against herpes zoster
    de Boer, Pieter T.
    Wilschut, Jan C.
    Postma, Maarten J.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (07) : 2048 - 2061
  • [7] Herpes zoster virus vaccine (Zostavax) for the prevention of shingles
    deYoung, G. Robert
    Baty, Philip J.
    [J]. AMERICAN FAMILY PHYSICIAN, 2007, 75 (12) : 1843 - 1844
  • [8] Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia
    Gillian M. Keating
    [J]. BioDrugs, 2016, 30 : 243 - 254
  • [9] Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia
    Keating, Gillian M.
    [J]. BIODRUGS, 2016, 30 (03) : 243 - 254
  • [10] DETERMINING THE OPTIMAL VACCINATION SCHEDULE FOR HERPES ZOSTER: A COST-EFFECTIVENESS ANALYSIS
    Le, Phuc H.
    Rothberg, Michael B.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S179 - S180
12345